Sorafenib Related Compound 7 with CAS No:2206827-12-3 is an impurity standard of Sorafenib. Sorafenib is a medication used in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant thyroid cancer. Chemically, it is a kinase inhibitor that targets multiple signaling pathways involved in tumor growth and angiogenesis. Sorafenib inhibits the activity of kinases such as Raf, VEGFR (vascular endothelial growth factor receptor), and PDGFR (platelet-derived growth factor receptor). By disrupting these pathways, sorafenib helps slow down cancer cell proliferation and reduce the growth of blood vessels that supply tumors. It is typically administered orally in tablet form and is considered an important therapeutic option in the management of certain advanced cancers. Buy high quality Sorafenib Related Compound 7 from from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Sorafenib Related Compound 7
Sorafenib Related Compound 7
CAT. No.
CP-S16022
CAS. No.
2206827-12-3
Mol. F.
C16H17N3O4
Mol. Wt.
315.33
Stock Status
Custom Synthesis
Category:
Impurity Standards
Synonyms:
PAPE-ethyl carbamate (USP)
Chemical Name:
Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate
Request for Quotation : Sorafenib Related Compound 7
Search by Keywords - Buy 2206827-12-3 | Purchase 2206827-12-3 | Order 2206827-12-3 | Enquire 2206827-12-3 | Price of 2206827-12-3 | 2206827-12-3 Cost | 2206827-12-3 Supplier | 2206827-12-3 Distributor | 2206827-12-3 Manufacturer | 2206827-12-3 Exporter | Sorafenib Related Compound 7 for Method Validation | Sorafenib Related Compound 7 for ANDA Filing | Sorafenib Related Compound 7 for Forced Degradation Studies | Sorafenib Related Compound 7 Identification Standards | Sorafenib Related Compound 7 for DMF Filing | Sorafenib
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.